Use of psychotropic medications in Italian children and adolescents

[1]  M. Parellada,et al.  Selective serotonin reuptake inhibitors: use in children and adolescents with major depressive disorder. , 2007, Actas espanolas de psiquiatria.

[2]  S. Kutcher,et al.  Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[3]  Christine B Phillips.  Medicine Goes to School: Teachers as Sickness Brokers for ADHD , 2006, PLoS medicine.

[4]  M. Kölch,et al.  Antidepressant use in children and adolescents in Germany. , 2006, Journal of child and adolescent psychopharmacology.

[5]  R. Berard,et al.  An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. , 2006, Journal of child and adolescent psychopharmacology.

[6]  D. Safer,et al.  Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents. , 2006, Journal of child and adolescent psychopharmacology.

[7]  J. Racoosin,et al.  Suicidality in pediatric patients treated with antidepressant drugs. , 2006, Archives of general psychiatry.

[8]  R. Findling,et al.  A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[9]  F. Goodwin,et al.  ACNP Task Force Report on SSRIs and Suicidal Behavior in Youth , 2006, Neuropsychopharmacology.

[10]  M. Bonati,et al.  Epidemiological Aspects of Drug Use , 2006 .

[11]  I. Choonara,et al.  Paediatric Clinical Pharmacology , 2006 .

[12]  A. Raz.  Perspectives on the Efficacy of Antidepressants for Child and Adolescent Depression , 2005, PLoS medicine.

[13]  K. Bennett,et al.  Overprescribing antidepressants to children: pharmacoepidemiological study in primary care , 2005, BMJ : British Medical Journal.

[14]  M. Bonati,et al.  The epidemiology of psychotropic drug use in children and adolescents , 2005, International review of psychiatry.

[15]  I. Wong,et al.  A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database , 2004, Archives of Disease in Childhood.

[16]  I. Smith,et al.  Risperidone in the Treatment of Disruptive Behavioral Symptoms in Children With Autistic and Other Pervasive Developmental Disorders , 2004, Pediatrics.

[17]  R. Hen,et al.  Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice , 2004, Science.

[18]  J. McGough,et al.  Second-generation antipsychotic medications in children and adolescents. , 2004, Journal of child and adolescent psychopharmacology.

[19]  R. Findling,et al.  A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. , 2004, The American journal of psychiatry.

[20]  É. Jacqz-Aigrain,et al.  Unlicensed and off-label use of psychotropic medications in French children: a prospective study , 2004 .

[21]  Peter Fonagy,et al.  Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data , 2004, The Lancet.

[22]  M. Haby,et al.  Efficacy and safety of antidepressants for children and adolescents , 2004, BMJ : British Medical Journal.

[23]  A. Gelenberg,et al.  Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. , 2004, Psychiatric services.

[24]  M. Bonati,et al.  Increase in non-evidence based use of antidepressants in children is cause for concern , 2004, BMJ : British Medical Journal.

[25]  W. Kondro.  Drug company experts advised staff to withhold data about SSRI use in children , 2004, Canadian Medical Association Journal.

[26]  S. E. Stewart,et al.  Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. , 2003, The American journal of psychiatry.

[27]  J. Amsterdam,et al.  When should a trial of fluoxetine for major depression be declared failed? , 2003, The American journal of psychiatry.

[28]  H. Hoyme,et al.  Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. , 2003, The Journal of pediatrics.

[29]  H. Hiscock,et al.  Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. , 2003, Pediatrics.

[30]  H. Tobi,et al.  Risk factors for unlicensed and off-label drug use in children outside the hospital. , 2003, Pediatrics.

[31]  T. Grady-Weliky.  Premenstrual dysphoric disorder , 2003 .

[32]  M. Aman,et al.  Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[33]  R. Findling,et al.  Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. , 2002, The American journal of psychiatry.

[34]  C. McDougle,et al.  Risperidone in children with autism and serious behavioral problems. , 2002, The New England journal of medicine.

[35]  Z. Zadik,et al.  Decreased growth during therapy with selective serotonin reuptake inhibitors. , 2002, Archives of pediatrics & adolescent medicine.

[36]  S. Macleod,et al.  Prescription medicine use by one million Canadian children , 2001 .

[37]  H. Tobi,et al.  Psychotropic medication in children: a study from the Netherlands. , 2001, Pediatrics.

[38]  N. Ryan,et al.  Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[39]  J. Coyle.  Psychotropic drug use in very young children. , 2000, JAMA.

[40]  E Scowen,et al.  Committee on Safety of Medicines. , 1978, British journal of anaesthesia.

[41]  J. Beresford,et al.  Experience with pericyazine in profoundly and severely retarded children. , 1972, Canadian Medical Association journal.

[42]  J. Bridge,et al.  Supportive psychotherapy, SSRIs, and MDD. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[43]  A. Thompson,et al.  Effects of the Committee on Safety of Medicines Advice on Antidepressant Prescribing to Children and Adolescents in the UK , 2006, Drug Safety.

[44]  P. Santosh,et al.  Effects of the Committee on Safety of Medicines Advice on Antidepressant Prescribing to Children and Adolescents in the UK , 2005, Drug safety.

[45]  R. Moynihan,et al.  Selling Sickness: How the World's Biggest Pharmaceutical Companies are Turning Us All into Patients , 2005 .

[46]  C. Crain.  SELLING SICKNESS: How the World's Biggest Pharmaceutical Companies Are Turning Us All Into Patients , 2005 .

[47]  F. Ponti,et al.  Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement , 2003, European Journal of Clinical Pharmacology.

[48]  S. Kutcher,et al.  Diagnosis and measurement of anxiety disorder in adolescents: a review of commonly used instruments. , 2003, Journal of child and adolescent psychopharmacology.

[49]  P. Accardo.  Risperidone in children with autism and serious behavioral problems. , 2003, The Journal of pediatrics.

[50]  C. Medawar,et al.  The Antidepressant WebMarketing depression and making medicines work. , 1997, The International journal of risk & safety in medicine.